5% Off
5% Off
marketed by ABBOTT HEALTHCARE PVT LTD - PC (OSVITA)
• 10TAB
₹181.74
M.R.P.: ₹191.31
5% Off
Inclusive of all taxes
LORSAID P tablet is a pain-relieving medication. it works by blocking certain chemical messengers which cause pain and inflammation. take this medication as prescribed by your doctor. the dose depends on your condition and how well it relieves your symptoms. do not take more than the recommended dose. the most common symptoms are nausea, vomiting, indigestion, stomach pain, and diarrhoea. if t
Hypersensitivity Edema Heart disease Kidney disease.
babies: it does not apply to babies.
lactating mother: consult your doctor before using this medication during breastfeeding.
pregnancy: consult your doctor before using this medication during pregnancy.
alcohol: it is unsafe to consume alcohol while taking this lornoxicam and paracetamol tablet, because alcohol can cause excessive drowsiness.
driving: it is not known whether to drive after taking this medication.
avoid driving if any symptoms affect your ability to drive.
consult your doctor.
kidney: lornoxicam and paracetamol tablet is safe to use in patients with kidney disease.
dose adjustment is not required.
liver: consult your doctor before taking this medication..
Nausea Vomiting Indigestion Stomach pain Diarrhea.
LORSAID P combination works by blocking certain chemical messengers which cause pain and inflammation..
If you miss a dose, take LORSAID P as soon as possible.
If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily.
Don't double the dose to catch up with the missed dose..
• LORSAID P are given in combination to treat pain and inflammation caused by various conditions like rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis • drink plenty of water to prevent dehydration • avoid spicy foods • tell your doctor if you have stomach and intestine ulcers • this medication may increase the risk of bleeding, better to Inform your doctor if you are planning for any surgeries.
• lornoxicam + abacavir: concurrent use may result in decreased excretion rate of abacavir which could result in a higher serum level • lornoxicam + acenocoumarol: concurrent use may result in increased risk of adverse effects of lornoxicam • lornoxicam + bismuth subgallate: concurrent use may result in decreased excretion rate of bismuth subgallate • lornoxicam + cefradine: concurrent use may result in increased risk of nephrotoxicity • paracetamol + articaine: concurrent use may result in increased risk of methemogloinemia • paracetamol + azithromycin: concurrent use may result in increased metabolism of azithromycin • paracetamol + imatinib: concurrent use may result in increased paracetamol levels • paracetamol + sulfinpyrazone: concurrent use may result in increased hepatotoxicity in paracetamol overdose.
100% Authentic
Easy Return